Watch for Insurance Flags or Rejects for Specialty Meds

March 2016

You'll have more opportunities to help patients with specialty meds...Repatha (evolocumab), Harvoni (ledipasvir/sofosbuvir), etc.

Specialty meds account for about half of new drugs approved in 2015...and these meds will make up over half of drug spending by 2017.

Be familiar with the basics of specialty meds.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote